Viva Biotech Holdings (1873.HK)
HKD 0.89
(-2.2%)
HKD 0.89
(-2.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 383.4 Million | 386.05 Million | 77.83 Million | 43.18 Million | 46.01 Million | 12.11 Million |
| Net Income | -55.95 Million | -528.47 Million | 287.54 Million | -386.88 Million | 265.87 Million | 90.55 Million |
| Depreciation & Amortization | 211.21 Million | 185.45 Million | 153.15 Million | 70.18 Million | 34.04 Million | 9.54 Million |
| Deferred income taxes | - | 93.93 Million | 147 Million | 28.48 Million | 3.15 Million | 22.08 Million |
| Stock-based compensation | 19 Million | 24.81 Million | 20.58 Million | 14.04 Million | 8.33 Million | 8.6 Million |
| Change in working capital | 31.41 Million | -118.75 Million | -167.58 Million | -42.52 Million | -11.48 Million | -31.72 Million |
| Other non-cash items | 344.2 Million | 729.07 Million | -362.87 Million | 359.87 Million | -253.9 Million | -64.86 Million |
| Investing Cash Flow | 439.17 Million | -372.8 Million | -868.83 Million | -3.84 Billion | -290.05 Million | -69.94 Million |
| Investments in PPE | -187.83 Million | -249.32 Million | -565.17 Million | -592.62 Million | -56.18 Million | -46.9 Million |
| Acquisitions | 3.84 Million | -81.2 Million | -210.87 Million | -2.5 Billion | -73.5 Million | - |
| Investment purchases | -64.45 Million | -233.23 Million | -2.1 Billion | -3.83 Billion | -1.79 Billion | - |
| Sales/Maturities of investments | 117.4 Million | 164.87 Million | 1.98 Billion | 3.73 Billion | 1.61 Billion | - |
| Other Investing Activities | 513.19 Million | 26.08 Million | 29.43 Million | -647.1 Million | 18.89 Million | -23.04 Million |
| Financing Cash Flow | -429.5 Million | -143.19 Million | -653.15 Million | 5.3 Billion | 984.86 Million | 179.47 Million |
| Debt repayment | -825.34 Million | -745.6 Million | -989.64 Million | -68.72 Million | -26.04 Million | -471 Thousand |
| Dividends payments | - | - | -16.27 Million | -51.79 Million | -135.83 Million | - |
| Common Stock Repurchased | -10.27 Million | - | -146.19 Million | -66.26 Million | -132.44 Million | - |
| Common Stock Issuance | - | - | 18.22 Million | 984.26 Million | 1.34 Billion | - |
| Other Financing Activities | 501 Million | 602.4 Million | 480.72 Million | 4.5 Billion | -187.21 Million | 179.95 Million |
| Accounts receivables | 30.43 Million | -22.3 Million | -98.51 Million | -41.52 Million | -7.85 Million | -29.1 Million |
| Accounts payables | - | -74.47 Million | 71.76 Million | -16.48 Million | -5.71 Million | - |
| Inventory | 57.04 Million | -96.44 Million | -69.07 Million | -1 Million | -3.63 Million | -1.57 Million |
| Other working capital | 44.02 Million | 74.47 Million | -71.76 Million | 16.48 Million | 5.71 Million | -1.04 Million |
| Cash at beginning of period | 678.56 Million | 800.94 Million | 2.3 Billion | 904.09 Million | 155.55 Million | 29.76 Million |
| Cash at end of period | 1.03 Billion | 678.56 Million | 800.94 Million | 2.3 Billion | 904.09 Million | 155.55 Million |
| Capital Expenditure | -187.83 Million | -249.32 Million | -565.17 Million | -592.62 Million | -56.18 Million | -46.9 Million |
| Effect of forex changes on cash | -35.32 Million | 7.57 Million | -63.34 Million | -96.9 Million | 7.71 Million | 4.14 Million |
| Net cash flow / Change in cash | 357.75 Million | -122.37 Million | -1.5 Billion | 1.4 Billion | 748.53 Million | 125.78 Million |
| Free Cash Flow | 195.56 Million | 136.72 Million | -487.34 Million | -549.44 Million | -10.17 Million | -34.79 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 116.8 Million | -117.12 Million | -55.95 Million | 1.01 Million | -528.47 Million | -437.27 Million |
| Depreciation & Amortization | 103.97 Million | 100.95 Million | 211.21 Million | 110.26 Million | 185.45 Million | 93.36 Million |
| Deferred income taxes | - | - | - | -143.9 Million | 93.93 Million | 30.08 Million |
| Stock-based compensation | -8.92 Million | 7.1 Million | 19 Million | 11.9 Million | 24.81 Million | 15.62 Million |
| Change in working capital | -31.01 Million | -38.66 Million | 31.41 Million | 170.17 Million | -118.75 Million | 26.39 Million |
| Other non-cash items | -28.51 Million | 113.69 Million | 344.2 Million | 24.09 Million | 729.07 Million | 595.32 Million |
| Investing Cash Flow | 201.59 Million | 530.59 Million | 439.17 Million | -91.42 Million | -372.8 Million | -192.75 Million |
| Investments in PPE | -128.35 Million | -86.07 Million | -187.83 Million | -101.6 Million | -249.32 Million | -112.64 Million |
| Acquisitions | - | - | 3.84 Million | - | -81.2 Million | -81.2 Million |
| Investment purchases | - | - | -64.45 Million | - | -233.23 Million | - |
| Sales/Maturities of investments | - | - | 117.4 Million | - | 164.87 Million | - |
| Other Investing Activities | 329.94 Million | 616.67 Million | 513.19 Million | 10.18 Million | 26.08 Million | 1.09 Million |
| Financing Cash Flow | -354.61 Million | -570.15 Million | -429.5 Million | 140.65 Million | -143.19 Million | -126.64 Million |
| Debt repayment | -362.89 Million | - | -825.34 Million | -175.62 Million | -745.6 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -10.27 Million | -10.27 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 8.28 Million | -559.88 Million | 501 Million | -34.96 Million | 602.4 Million | -126.64 Million |
| Accounts receivables | -44 Million | -53.03 Million | 30.43 Million | 83.47 Million | -22.3 Million | 31.11 Million |
| Accounts payables | - | - | - | - | -74.47 Million | - |
| Inventory | 33.02 Million | 8.51 Million | 57.04 Million | 48.52 Million | -96.44 Million | -76.82 Million |
| Other working capital | -20.03 Million | 5.85 Million | 44.02 Million | 38.17 Million | 74.47 Million | 72.1 Million |
| Cash at beginning of period | 1.03 Billion | 1.07 Billion | 678.56 Million | 678.56 Million | 800.94 Million | 712.19 Million |
| Cash at end of period | 1.03 Billion | 1.07 Billion | 1.03 Billion | 1.07 Billion | 678.56 Million | 678.56 Million |
| Capital Expenditure | -128.35 Million | -86.07 Million | -187.83 Million | -101.6 Million | -249.32 Million | -112.64 Million |
| Effect of forex changes on cash | 611 Thousand | -63.69 Million | -35.32 Million | 28.36 Million | 7.57 Million | -7.65 Million |
| Net cash flow / Change in cash | -81 Thousand | - | 357.75 Million | 395.04 Million | -122.37 Million | -33.62 Million |
| Free Cash Flow | 23.97 Million | -20.11 Million | 195.56 Million | 215.84 Million | 136.72 Million | 180.78 Million |
1453
MV4
BNP
002554
EXTO
IZNN